Physician profile
Marlene Chavez
NPI 1518502517
$1,429.99
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $913 · 2022: $339 · 2023: $83.93 · 2024: $94.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $217.96 | 2021-2024 | Trelegy Ellipta |
| Novo Nordisk INC | $172.33 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $135.02 | 2021-2022 | |
| Dexcom, INC. | $97.49 | 2021-2023 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $95.80 | 2021-2023 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $95.07 | 2021 | |
| Novartis Pharmaceuticals Corporation | $94.24 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.22 | 2022 | |
| Lilly USA, LLC | $68.13 | 2021-2022 | |
| Amgen INC. | $62.20 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.86 | 2021 | |
| Amarin Pharma, INC. | $49.23 | 2021 | |
| Pfizer INC. | $41.71 | 2021-2022 | |
| Cranial Technologies, INC | $31.77 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $27.47 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.78 | 2021 | |
| Hologic Sales and Service, LLC | $20.09 | 2024 | Aptima, Thinprep 2000 Processor |
| Ibsa Pharma INC. | $18.49 | 2021 | |
| Sanofi-Aventis U.S. LLC | $18.10 | 2021 | |
| Merck Sharp & Dohme LLC | $16.59 | 2022 | |
| Corcept Therapeutics | $15.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlene Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.